Status:
COMPLETED
Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease
Lead Sponsor:
Region Skane
Conditions:
Rheumatoid Arthritis
Systemic Lupus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The overall objective of this project is to study the influence of modern anti-inflammatory treatments in established inflammatory rheumatic diseases (IRD) on antibody response elicited by pneumococca...
Eligibility Criteria
Inclusion
- Adult patients with IRD receiving active anti-rheumatic treatments with DMARDs or biological remedies are offered to participate in the study. The protocol permits stratification for prednisolone usage.
Exclusion
- known allergy/intolerance of pneumococcal vaccine
- pregnancy
- active infection
Key Trial Info
Start Date :
June 14 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03762824
Start Date
June 14 2016
End Date
December 21 2020
Last Update
March 29 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.